Matrix-induced Autologous Chondrocyte Implantation (mACI) Versus Autologous Matrix-induced Chondrogenesis (AMIC) for Chondral Defects of the Knee: a Systematic Review
Overview
Authors
Affiliations
Introduction: Chondral defects of the knee are common and their treatment is challenging.
Source Of Data: PubMed, Google scholar, Embase and Scopus databases.
Areas Of Agreement: Both autologous matrix-induced chondrogenesis (AMIC) and membrane-induced autologous chondrocyte implantation (mACI) have been used to manage chondral defects of the knee.
Areas Of Controversy: It is debated whether AMIC and mACI provide equivalent outcomes for the management of chondral defects in the knee at midterm follow-up. Despite the large number of clinical studies, the optimal treatment is still controversial.
Growing Points: To investigate whether AMIC provide superior outcomes than mACI at midterm follow-up.
Areas Timely For Developing Research: AMIC may provide better outcomes than mACI for chondral defects of the knee. Further studies are required to verify these results in a clinical setting.
Chang W, Atzmon R, Vel M, Lin K, Abrams G, Sherman S Orthop J Sports Med. 2025; 13(2):23259671241308855.
PMID: 39931633 PMC: 11808760. DOI: 10.1177/23259671241308855.
Emerging Strategies in Cartilage Repair and Joint Preservation.
Focsa M, Florescu S, Gogulescu A Medicina (Kaunas). 2025; 61(1).
PMID: 39859006 PMC: 11766557. DOI: 10.3390/medicina61010024.
Gebhardt S, Vollmer M, Zimmerer A, Rochel I, Balcarek P, Niemeyer P Orthop J Sports Med. 2024; 12(7):23259671241255672.
PMID: 39070901 PMC: 11273558. DOI: 10.1177/23259671241255672.
Shimomura K, Ando W, Hart D, Nakamura N Regen Ther. 2024; 26:124-131.
PMID: 38883147 PMC: 11176953. DOI: 10.1016/j.reth.2024.05.007.
Cognetti D, DeFoor M, Yuan T, Sheean A Bioengineering (Basel). 2024; 11(3).
PMID: 38534520 PMC: 10967907. DOI: 10.3390/bioengineering11030246.